Instituto de Investigación Sanitaria de Santiago de Compostela (IDIS)
Research center
Università di Perugia
Perugia, ItaliaPublications in collaboration with researchers from Università di Perugia (38)
2023
2022
-
From Serendipity to Rational Identification of the 5,6,7,8-Tetrahydrobenzo[4,5]thieno[2,3-d]pyrimidin-4(3H)-one Core as a New Chemotype of AKT1 Inhibitors for Acute Myeloid Leukemia
Pharmaceutics, Vol. 14, Núm. 11
-
Improving empiric antibiotic prescribing in pediatric bloodstream infections: a potential application of weighted-incidence syndromic combination antibiograms (WISCA)
Expert Review of Anti-Infective Therapy, Vol. 20, Núm. 3, pp. 445-456
-
New insights into the genetic etiology of Alzheimer's disease and related dementias
Nature genetics, Vol. 54, Núm. 4, pp. 412-436
-
Publisher Correction: Stroke genetics informs drug discovery and risk prediction across ancestries (Nature, (2022), 611, 7934, (115-123), 10.1038/s41586-022-05165-3)
Nature
-
Stroke genetics informs drug discovery and risk prediction across ancestries
Nature, Vol. 611, Núm. 7934, pp. 115-123
2021
-
Common variants in Alzheimer's disease and risk stratification by polygenic risk scores
Nature communications, Vol. 12, Núm. 1, pp. 3417
-
Pharmacological inactivation of the prion protein by targeting a folding intermediate
Communications Biology, Vol. 4, Núm. 1
-
Synthesis and characterization of 1,2,4-triazolo[1,5-a]pyrimidine-2-carboxamide-based compounds targeting the PA-PB1 interface of influenza A virus polymerase
European Journal of Medicinal Chemistry, Vol. 209
2020
-
Baseline predictors for visual acuity loss during observation in diabetic macular oedema with good baseline visual acuity
Acta Ophthalmologica, Vol. 98, Núm. 7, pp. e801-e806
2019
-
Analysis of Outcomes in Ischemic vs Nonischemic Cardiomyopathy in Patients with Atrial Fibrillation: A Report from the GARFIELD-AF Registry
JAMA Cardiology, Vol. 4, Núm. 6, pp. 526-548
-
Author Correction: Genetic meta-analysis of diagnosed Alzheimer’s disease identifies new risk loci and implicates Aβ, tau, immunity and lipid processing (Nature Genetics, (2019), 51, 3, (414-430), 10.1038/s41588-019-0358-2)
Nature Genetics
-
Discovery of potent p38α MAPK inhibitors through a funnel like workflow combining in silico screening and in vitro validation
European Journal of Medicinal Chemistry, Vol. 182
-
Genetic meta-analysis of diagnosed Alzheimer’s disease identifies new risk loci and implicates Aβ, tau, immunity and lipid processing
Nature Genetics, Vol. 51, Núm. 3, pp. 414-430
-
Real-world outcomes of non-responding diabetic macular edema treated with continued anti-VEGF therapy versus early switch to dexamethasone implant: 2-year results
Acta Diabetologica, Vol. 56, Núm. 12, pp. 1341-1350
-
Real-world outcomes of observation and treatment in diabetic macular edema with very good visual acuity: the OBTAIN study
Acta Diabetologica
-
Standards of practice in acute ischemic stroke intervention: International recommendations
Interventional Neuroradiology, Vol. 25, Núm. 1, pp. 31-37
2018
-
2-Phenylquinazolinones as dual-activity tankyrase-kinase inhibitors
Scientific Reports, Vol. 8, Núm. 1
-
Characteristics of patients with atrial fibrillation prescribed antiplatelet monotherapy compared with those on anticoagulants: Insights from the GARFIELD-AF registry
European Heart Journal, Vol. 39, Núm. 6, pp. 464-473
-
Meningococcal b vaccine immunogenicity in children with defects in complement and splenic function
Pediatrics, Vol. 142, Núm. 3